Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-08

FDA Approved: CINACALCET — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves Aurobindo Pharma Limited's original application for cinacalcet (generic) to treat secondary hyperparathyroidism in adults with chronic kidney disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cinacalcet (cinacalcet hydrochloride)

Snippet

ORIG AP for CINACALCET (CINACALCET)